baicalin has been researched along with Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, F; Cheng, Y; Chu, J; Fang, Y; Liu, H; Peng, J; Shen, A; Wang, D; Wei, L; Wu, M; Xie, Q; Yan, M; Yang, Y | 1 |
| Chen, Y; Ding, L; Jia, C; Wang, W; Zhang, T; Zhang, Y; Zhu, W | 1 |
2 other study(ies) available for baicalin and Hypertension
| Article | Year |
|---|---|
Baicalin attenuates angiotensin II-induced blood pressure elevation and modulates MLCK/p-MLC signaling pathway.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Blood Pressure; Calcium Signaling; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Flavonoids; Hypertension; Hypoglycemic Agents; Male; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Myosin Light Chains; Myosin-Light-Chain Kinase; Phosphorylation; Rats, Wistar | 2021 |
Baicalin relaxes vascular smooth muscle and lowers blood pressure in spontaneously hypertensive rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Dose-Response Relationship, Drug; Flavonoids; Hypertension; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasodilator Agents | 2019 |